Foundation Medicine spotlights scientific achievements at ESMO Congress in 11 abstracts, including one oral presentation, across seven cancer types.

With the NMPA's approval, Mirxes will significantly scale up the commercialization of GASTROClear™ in China. The company ...

The non-invasive blood test helps in the early detection of the fifth leading cause of cancer deaths globally.

Importantly, stomach cancer is also being diagnosed in an increasing number of younger people -- that is, those younger than 50. In 2019, these cancers -- also called early-onset -- accounted for ...

Adding an esophagogastroduodenoscopy to a screening or surveillance colonoscopy detected upper-GI cancers and preneoplastic ...

The European Society for Medical Oncology "Living Guideline" for Gastric Cancer suggests that narrow-band imaging or ...

The company recently reported that the four-protein test with algorithm-based analysis performed with 83.5 percent sensitivity and 90.3 percent specificity.

Some genetics experts felt the event raised awareness of the importance of testing, while others had mixed feelings amid ...

The very mention of the name Ivo Figueiredo, who departed from this world some years ago, brings back great memories of past times spent in his company. He ...

Learn how to interpret atypical SIBO breath test results—including flat-line, high baseline hydrogen, and delayed motility spikes—to uncover functional gut health insights and guide individualized ...

Astellas Pharma Canada Inc. is proud to announce that VYLOY® (zolbetuximab) is now funded by the Ontario Drug Benefit Program under the New Drug Funding Program ...

We'll likely have to wait a while to see Firefly Aerospace's Alpha rocket take to the skies again. The first stage of the rocket that Firefly was prepping to make Alpha's seventh-ever flight exploded ...